郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价FR-190997, a nonpeptide bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys.

期刊:Drug development research发表年份:2014作者:Najam A Sharif; Parvaneh Katoli; Daniel Scott; Linya Li; Curtis Kelly; Shouxi Xu; Shahid Husain; Carol Toris; Craig Crosson

药效评价A novel class of succinimide-derived negative allosteric modulators of metabotropic glutamate receptor subtype 1 provides insight into a disconnect in activity between the rat and human receptors.

期刊:ACS chemical neuroscience发表年份:2014作者:Hyekyung P Cho; Darren W Engers; Daryl F Venable; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn; Kyle A Emmitte; Alice L Rodriguez

药效评价Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.

期刊:Molecular pharmacology发表年份:2014作者:Douglas A Schober; Carrie H Croy; Hongling Xiao; Arthur Christopoulos; Christian C Felder

药效评价Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.

期刊:Journal of medicinal chemistry发表年份:2014作者:Briana J Davie; Celine Valant; Jonathan M White; Patrick M Sexton; Ben Capuano; Arthur Christopoulos; Peter J Scammells